Stay updated on Andexanet Alfa Reversal in Bleeding: Anticoagulant Clinical Trial

Sign up to get notified when there's something new on the Andexanet Alfa Reversal in Bleeding: Anticoagulant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Andexanet Alfa Reversal in Bleeding: Anticoagulant Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) was added and an older funding/operating status notice (v3.4.1) was removed; these changes affect site messaging and versioning but do not modify study records or primary content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T02:19:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows a site-wide notice about government funding and operations. It also updates the revision tag to v3.4.1, replacing v3.4.0.
    Difference
    0.7%
    Check dated 2026-02-04T00:32:25.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The Record History UI now includes a glossary toggle, color-coded highlights for additions and deletions, and an updated revision label (v3.4.0) replacing the prior version.
    Difference
    0.9%
    Check dated 2026-01-27T22:21:23.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The history shows a minor software revision from v3.3.3 to v3.3.4 with no changes to study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-13T17:44:37.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The history adds a new revision entry (v3.3.3) and removes HHS Vulnerability Disclosure and Revision: v3.3.2, affecting only the page metadata rather than the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T01:50:00.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Added Revision: v3.3.1 and removed the notices about funding lapse and the earlier Revision: v3.2.0 as part of the page history. These are administrative backend updates that do not affect the study data, eligibility, or results on the NCT02329327 record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-24T10:57:26.000Z thumbnail image

Stay in the know with updates to Andexanet Alfa Reversal in Bleeding: Anticoagulant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa Reversal in Bleeding: Anticoagulant Clinical Trial page.